The Medical Device Calibration and Testing market is primarily divided by application, a taxonomy that clarifies revenue drivers across distinct clinical domains. Diagnostic imaging equipment—such as MRI, CT, and X‑ray systems—accounts for the largest share, roughly 30 % of total market value, because frequent performance verification is mandated by regulatory bodies to ensure image fidelity and patient safety. Therapeutic devices, including radiation therapy units, infusion pumps, and electrosurgical generators, represent about 25 % of the market; their calibration cycles are intensive due to direct patient treatment impact. Patient monitoring devices (e.g., ECG, pulse oximeters, and wearable telemetry) contribute roughly 20 %, reflecting high unit volumes and continuous usage in acute‑care settings. Surgical instruments equipped with electronic or optical components capture 15 % of the market, driven by the need for precise intra‑operative functionality. Finally, in‑vitro diagnostic (IVD) platforms occupy the remaining 10 %, where assay accuracy hinges on rigorous testing. This Medical Device Calibration and Testing segmentation by application underpins the overall market size by aligning service spend with clinical risk profiles.